Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 798 of 1,261
  1. US 8809264

    Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  2. US 8808715

    Methods and compositions for modulating keratinocyte function

    Georgia Regents Research Institute, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  3. US 8809016

    Nucleic acids encoding modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  4. US 8808735

    Fast wet-massing method for the preparation of calcium-containing compositions

    TAKEDA NYCOMED AS · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  5. US 8808698

    Methods for inhibition of lymphangiogenesis and tumor metastasis

    The Regents of the University of California · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  6. US 8808866

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  7. US 8808714

    Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

    Supernus Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  8. US 8808684

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  9. US 8809489

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  10. US 8802868

    Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  11. US 8802689

    Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

    The Regents of the University of California · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  12. US 8802857

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  13. US 8802856

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  14. US 8802699

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  15. US 8802090

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  16. US 8802695

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  17. US 8802698

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  18. US 8802854

    Crystalline forms of Prasugrel salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  19. US 8802835

    Proteins with repetitive bacterial-Ig-like (Big) domains present in leptospira species

    The United States of America as represented by the Department of Veteran Affairs · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  20. US 8802773

    In vivo polynucleotide delivery conjugates having enzyme sensitive linkages

    Arrowhead Madison, Inc. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  21. US 8802700

    Modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  22. US 8802733

    Aldehyde dehydrogenase inhibitors as novel depigmenting agents

    The Board of Regents of the University of Texas System · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  23. US 8802709

    Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  24. US 8802074

    Polymers functionalized with ion-specific recognition elements

    The Board of Regents of the University of Texas System · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.